Skip to main content

Table 1 Characteristics of CPP patients and cancer patients. Norway, 2015-2017

From: Equitable access to cancer patient pathways in Norway – a national registry-based study

  Lung Colorectal Prostate Breast Total
  Male Female Male Female    
  CPP patients, n (% CPP patients without the cancer diagnosis)
Patients 7 461 (46.3%) 6 428 (43.9%) 15 802 (64.6%) 16 824 (69.3%) 19 897 (48.7%) 23 279 (56.5%) 89 691 (56.9%)
Year
2015 2 375 (47.2%) 2 055 (43.5%) 4 726 (63.0%) 5 109 (68.1%) 6 113 (51.1%) 7 487 (56.8%) 27 865 (56.9%)
2016 2 521 (45.8%) 2 143 (44.1%) 5 660 (65.6%) 5 935 (69.6%) 6 992 (47.6%) 7 785 (56.9%) 31 036 (57.0%)
2017 2 565 (45.9%) 2 230 (44.1%) 5 416 (65.0%) 5 780 (70.1%) 6 792 (47.6%) 8 007 (56.0%) 30 790 (56.7%)
Age group        
Under 50 344 (78.5%) 294 (70.4%) 1 546 (83.4%) 1 772 (84.8%) 389 (70.2%) 8 511 (79.3%) 12 856 (80.1%)
50-59 838 (60.3%) 789 (50.6%) 2 480 (74.4%) 2 493 (78.2%) 2 841 (59.0%) 5 106 (52.5%) 14 547 (62.2%)
60-69 2 251 (45.3%) 1 989 (42.7%) 4 240 (62.9%) 4 088 (70.9%) 8 533 (51.3%) 4 888 (39.0%) 25 989 (52.8%)
70-79 2 778 (40.8%) 2 372 (39.0%) 4 816 (59.4%) 5 080 (65.7%) 6 720 (42.6%) 3 216 (40.9%) 24 982 (49.8%)
80-90 1 250 (42.2%) 984 (44.7%) 2 720 (56.9%) 3 391 (58.1%) 1 414 (35.1%) 1 558 (32.6%) 11 317 (48.5%)
Income        
Low 1 567 (42.0%) 2 936 (41.9%) 2 573 (63.1%) 6 933 (66.0%) 2 208 (47.0%) 6 402 (52.6%) 22 619 (55.2%)
Medium 4 259 (44.6%) 2 838 (44.3%) 8 258 (63.4%) 7 563 (70.5%) 9 696 (46.1%) 11 117 (56.9%) 43 731 (56.1%)
High 1 635 (54.9%) 654 (51.1%) 4 971 (67.5%) 2 328 (75.2%) 7 993 (52.2%) 5 760 (60.3%) 23 341 (59.9%)
Education        
Low 2 641 (42.5%) 2 553 (41.7%) 4 209 (65.2%) 5 312 (67.8%) 3 889 (45.9%) 5 132 (55.9%) 23 736 (55.6%)
Medium 3 683 (46.6%) 2 947 (43.1%) 7 759 (64.1%) 7 603 (68.3%) 10 108 (47.9%) 9 707 (53.1%) 41 807 (55.3%)
High 1 137 (54.4%) 928 (52.5%) 3 834 (65.0%) 3 909 (73.3%) 5 900 (51.8%) 8 440 (60.9%) 24 148 (60.7%)
Comorbidity        
Low 5 118 (48.5%) 4 725 (45.7%) 13 020 (64.8%) 14 701 (69.7%) 17 868 (48.8%) 21 991 (56.9%) 77 423 (57.5%)
Medium 1 484 (41.9%) 1 235 (37.7%) 1 739 (62.8%) 1 403 (69.1%) 1 420 (46.8%) 833 (51.9%) 8 114 (52.3%)
High 859 (41.1%) 468 (41.7%) 1 043 (65.4%) 720 (61.4%) 609 (49.6%) 455 (49.2%) 4 154 (52.9%)
Travel time        
Short 5 695 (47.0%) 5 052 (44.5%) 12 384 (64.9%) 13 417 (69.7%) 15 535 (49.4%) 19 024 (56.5%) 71 107 (57.3%)
Medium 1 018 (44.5%) 820 (40.1%) 2 052 (63.4%) 2 044 (66.4%) 2 646 (45.8%) 2 726 (58.6%) 11 306 (55.3%)
Long 747 (43.8%) 556 (43.7%) 1 366 (63.7%) 1 363 (69.8%) 1 714 (46.9%) 1 529 (53.6%) 7 275 (55.2%)
Hospital referral area        
Min 32.4% 29.8% 42.5% 48.1% 28.9% 36.8% 45.4%
Max 66.2% 61.3% 83.2% 84.0% 59.5% 73.1% 69.4%
SD 8.4% 7.7% 10.9% 10.0% 6.9% 9.2% 5.9%
EQ 2.0 2.1 2.0 1.7 2.1 2.0 1.5
  Cancer patients, n (% cancer patients included in CPP)
Patients 5 076 (78.9%) 4 629 (77.9%) 6 836 (81.8%) 6 471 (79.8%) 15 864 (64.4%) 10 911 (92.7%) 49 787 (77.7%)
Year        
2015 1 650 (73.8%) 1 543 (73.0%) 2 252 (77.2%) 2 131 (75.5%) 5 136 (55.2%) 3 609 (89.3%) 16 321 (72.0%)
2016 1 682 (80.8%) 1 531 (78.8%) 2 307 (83.5%) 2 207 (81.8%) 5 378 (67.6%) 3 549 (94.5%) 16 654 (79.8%)
2017 1 744 (82.0%) 1 555 (82.0%) 2 277 (84.7%) 2 133 (82.1%) 5 350 (69.9%) 3 753 (94.3%) 16 812 (81.3%)
Age group        
Under 50 87 (85.1%) 105 (84.8%) 366 (69.9%) 382 (70.4%) 160 (71.3%) 1 886 (93.2%) 2 986 (85.7%)
50-59 396 (84.1%) 461 (84.4%) 752 (84.6%) 674 (80.7%) 1 667 (69.2%) 2 613 (92.9%) 6 563 (83.5%)
60-69 1 503 (81.5%) 1 376 (82.6%) 1 860 (84.4%) 1 434 (82.8%) 5 939 (69.7%) 3 207 (92.9%) 15 319 (79.9%)
70-79 2 039 (80.9%) 1 821 (79.5%) 2 350 (83.4%) 2 110 (82.5%) 5 920 (65.5%) 2 063 (92.2%) 16 303 (77.1%)
80-90 1 051 (69.0%) 866 (63.2%) 1 508 (77.7%) 1 871 (76.1%) 2 178 (42.4%) 1 142 (91.9%) 8 616 (67.8%)
Income        
Low 1 257 (72.2%) 2 273 (74.7%) 1 204 (78.7%) 2 984 (79.0%) 2 047 (56.8%) 3 336 (91.0%) 13 101 (77.2%)
Medium 2 942 (80.2%) 1 985 (80.1%) 3 702 (81.8%) 2 777 (80.3%) 8 199 (63.8%) 5 136 (93.3%) 24 741 (77.7%)
High 877 (84.4%) 371 (86.3%) 1 930 (83.8%) 710 (81.4%) 5 618 (67.9%) 2 439 (93.8%) 11 945 (78.4%)
Education        
Low 1 965 (77.3%) 1 978 (75.2%) 1 827 (80.1%) 2 181 (78.3%) 3 446 (61.0%) 2 473 (91.5%) 13 870 (76.0%)
Medium 2 474 (79.6%) 2 109 (79.6%) 3 393 (82.2%) 2 987 (80.7%) 8 000 (65.8%) 4 916 (92.7%) 23 879 (78.2%)
High 637 (81.5%) 542 (81.5%) 1 616 (82.9%) 1 303 (80.2%) 4 418 (64.4%) 3 522 (93.6%) 12 038 (78.8%)
Comorbidity        
Low 3 243 (81.4%) 3 179 (80.7%) 5 519 (83.1%) 5 498 (81.0%) 13 813 (66.2%) 10 219 (92.8%) 41 471 (79.3%)
Medium 1 110 (77.7%) 1 009 (76.3%) 820 (78.9%) 584 (74.1%) 1 352 (55.9%) 434 (92.4%) 5 309 (72.9%)
High 723 (70.0%) 441 (61.9%) 497 (72.6%) 389 (71.5%) 699 (43.9%) 258 (89.5%) 3 007 (65.0%)
Travel time        
Short 3 850 (78.4%) 3 620 (77.5%) 5 351 (81.2%) 5 129 (79.3%) 12 291 (64.0%) 8 915 (92.8%) 39 156 (77.6%)
Medium 708 (79.9%) 603 (81.3%) 900 (83.6%) 842 (81.5%) 2 202 (65.1%) 1 217 (92.8%) 6 472 (78.1%)
Long 518 (81.3%) 406 (77.1%) 585 (84.8%) 500 (82.2%) 1 371 (66.2%) 779 (91.1%) 4 159 (78.4%)
Hospital referral area        
Min 69.0% 67.6% 69.4% 67.2% 44.8% 82.6% 72.7%
Max 87.7% 86.8% 89.9% 88.1% 74.6% 98.4% 84.5%
SD 5.5% 5.9% 5.1% 4.8% 8.5% 3.6% 3.8%
EQ 1.3 1.3 1.3 1.3 1.7 1.2 1.2
  1. Min and Max are minimum and maximum proportions in the 21 hospital referral areas. EQ - Extremal quotient, EQ=Max/Min. For details on the 21 hospital referral areas see Appendix B (Table B1)